A comparative analysis of 203 pancreatic cancer patients between 2010-2015 and 2016-2021 revealed significant improvements in outcomes due to multidisciplinary treatment. Patients in the latter group had higher preoperative chemotherapy rates (95%) and lower morbidity and pancreatic fistula rates. Overall survival notably improved, from 26.0 to 48.2 months, emphasizing the efficacy of radical resection, including arterial resection, for those with arterial involvement in pancreatic cancer.
Comparative Study by Hirose Y, Oba A (…) Takahashi Y et 13 al. in BJS Open
© The Author(s) 2025. Published by Oxford University Press on behalf of BJS Foundation Ltd.